COVAXX
COVAXX, also known as C19 Corp. and C19 Corporation, is an American biotechnology company based in Hauppauge, New York. It was previously a division of United Biomedical and is now a subsidiary of Vaxxinity. It is developing a "multitope protein/peptide-based" COVID-19 vaccine candidate called UB-612, with phase 2 clinical trials taking place at the University of Nebraska Medical Center.